|
US4235877A
(en)
|
1979-06-27 |
1980-11-25 |
Merck & Co., Inc. |
Liposome particle containing viral or bacterial antigenic subunit
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
WO1988009797A1
(en)
|
1987-06-05 |
1988-12-15 |
The United States Of America, As Represented By Th |
Autocrine motility factors in cancer diagnosis and management
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
US4940460A
(en)
|
1987-06-19 |
1990-07-10 |
Bioject, Inc. |
Patient-fillable and non-invasive hypodermic injection device assembly
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
DE3734306A1
(de)
|
1987-10-10 |
1989-04-27 |
Pfeiffer Erich Gmbh & Co Kg |
Austragvorrichtung fuer fliessfaehige medien
|
|
US5339163A
(en)
|
1988-03-16 |
1994-08-16 |
Canon Kabushiki Kaisha |
Automatic exposure control device using plural image plane detection areas
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
JP3237842B2
(ja)
|
1988-12-16 |
2001-12-10 |
オランダ国 |
ニューモリシンミュータント及びそれから製造されたニューモコッカルワクチン
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
DE4005528C2
(de)
|
1990-02-22 |
1998-01-15 |
Pfeiffer Erich Gmbh & Co Kg |
Austragvorrichtung für Medien
|
|
US5476929A
(en)
|
1991-02-15 |
1995-12-19 |
Uab Research Foundation |
Structural gene of pneumococcal protein
|
|
FI933580L
(fi)
|
1991-02-15 |
1993-10-13 |
Uab Research Foundation |
Strukturgen av pneumokockprotein
|
|
US6592876B1
(en)
|
1993-04-20 |
2003-07-15 |
Uab Research Foundation |
Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
|
|
GB9118204D0
(en)
|
1991-08-23 |
1991-10-09 |
Weston Terence E |
Needle-less injector
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5569189A
(en)
|
1992-09-28 |
1996-10-29 |
Equidyne Systems, Inc. |
hypodermic jet injector
|
|
US5334144A
(en)
|
1992-10-30 |
1994-08-02 |
Becton, Dickinson And Company |
Single use disposable needleless injector
|
|
KR100310510B1
(ko)
|
1993-03-23 |
2002-07-04 |
장 스테판느 |
3-0-탈아세틸화모노포스포릴지질a를함유하는백신조성물
|
|
PT729473E
(pt)
|
1993-11-17 |
2001-02-28 |
Deutsche Om Arzneimittel Gmbh |
Dissacaridos de glucosamina metodo para a sua preparacao composicao farmaceutica contendo os mesmos e sua utilizacao
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
WO1995024176A1
(en)
|
1994-03-07 |
1995-09-14 |
Bioject, Inc. |
Ampule filling device
|
|
US5466220A
(en)
|
1994-03-08 |
1995-11-14 |
Bioject, Inc. |
Drug vial mixing and transfer device
|
|
US5599302A
(en)
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
|
US5893397A
(en)
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
|
WO1997041151A2
(en)
|
1996-05-01 |
1997-11-06 |
The Rockefeller University |
Choline binding proteins for anti-pneumococcal vaccines
|
|
ATE234129T1
(de)
|
1996-06-18 |
2003-03-15 |
Alza Corp |
Vorrichtung zur verbesserung der transdermalen verabreichung von medikamenten oder der abnahme von körperflüssigkeiten
|
|
EP0956289A4
(en)
|
1996-08-16 |
2004-10-13 |
Smithkline Beecham Corp |
NOVEL PROKARYOTA POLYNUCLEOTIDES AND POLYPEPTIDES AND USES THEREOF
|
|
ATE348887T1
(de)
|
1996-10-31 |
2007-01-15 |
Human Genome Sciences Inc |
Streptococcus pneumoniae antigene und impfstoffe
|
|
AU5355398A
(en)
|
1996-11-12 |
1998-06-03 |
Regents Of The University Of Minnesota |
C3 binding protein of (streptococcus pneumoniae)
|
|
US5980898A
(en)
|
1996-11-14 |
1999-11-09 |
The United States Of America As Represented By The U.S. Army Medical Research & Material Command |
Adjuvant for transcutaneous immunization
|
|
KR100453132B1
(ko)
|
1996-12-20 |
2004-10-15 |
앨자 코포레이션 |
경피 약제 플럭스를 향상시키기 위한 장치 및 방법
|
|
DE19708537A1
(de)
|
1997-03-03 |
1998-09-10 |
Biotechnolog Forschung Gmbh |
Neues Oberflächenprotein (SpsA-Protein) von Streptococcus pneumoniae etc.
|
|
US6764840B2
(en)
|
1997-05-08 |
2004-07-20 |
Corixa Corporation |
Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
|
|
US6113918A
(en)
|
1997-05-08 |
2000-09-05 |
Ribi Immunochem Research, Inc. |
Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
|
|
US6303347B1
(en)
|
1997-05-08 |
2001-10-16 |
Corixa Corporation |
Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
|
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
|
US6800744B1
(en)
|
1997-07-02 |
2004-10-05 |
Genome Therapeutics Corporation |
Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
|
|
AU740956B2
(en)
|
1997-07-21 |
2001-11-15 |
Baxter Healthcare Sa |
Modified immunogenic pneumolysin compositions as vaccines
|
|
EP1017828A1
(en)
|
1997-09-24 |
2000-07-12 |
Regents Of The University Of Minnesota |
HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE)
|
|
CN1285753A
(zh)
|
1997-12-02 |
2001-02-28 |
鲍德杰克特疫苗公司 |
透皮给药微粒疫苗组合物
|
|
IT1298087B1
(it)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
|
|
AU3479699A
(en)
|
1998-04-07 |
1999-10-25 |
St. Jude Children's Research Hospital |
A polypeptide comprising the amino acid of an n-terminal choline binding proteina truncate, vaccine derived therefrom and uses thereof
|
|
NZ530277A
(en)
|
1998-04-07 |
2005-08-26 |
Medimmune Inc |
Derivatives of pneumococcal choline binding proteins for vaccines
|
|
WO1999053940A1
(en)
|
1998-04-23 |
1999-10-28 |
Uab Research Foundation |
PNEUMOCOCCAL SURFACE PROTEIN C(PspC), EPITOPIC REGIONS AND STRAIN SELECTION THEREOF, AND USES THEREFOR
|
|
EP1089913A1
(fr)
|
1998-06-08 |
2001-04-11 |
SCA Emballage France |
Emballage a remise a plat rapide
|
|
SK287073B6
(sk)
|
1998-06-30 |
2009-11-05 |
Om Pharma |
N-Acyldipeptidový derivát, spôsob jeho prípravy a farmaceutický prostriedok, ktorý ho obsahuje
|
|
EP1115875A1
(en)
|
1998-09-24 |
2001-07-18 |
Regents Of The University Of Minnesota |
Human complement c3-degrading polypeptide from streptococcus pneumoniae
|
|
WO2000030299A1
(en)
|
1998-11-17 |
2000-05-25 |
Schlumberger Technology Corporation |
Transmitting information over a communication link
|
|
AU2027400A
(en)
|
1998-11-19 |
2000-06-05 |
St. Jude Children's Research Hospital |
Identification and characterization of novel pneumococcal choline binding proteins, cbpg and cbpd, and diagnostic and therapeutic uses thereof
|
|
CA2355364C
(en)
*
|
1998-12-21 |
2014-03-18 |
Medimmune, Inc. |
Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
|
|
PL205041B1
(pl)
|
1998-12-23 |
2010-03-31 |
Id Biomedical Corp |
Izolowany polinukleotyd, wektor zawierający izolowany polinukleotyd, komórka gospodarza transfekowana lub transformowana za pomocą tego wektora, sposób wytwarzania polipeptydu kodowanego przez izolowany polinukleotyd, izolowany polipeptyd, chimeryczny polipeptyd, kompozycja do szczepionek zawierająca polipeptyd oraz jej zastosowanie w leczeniu lub zapobieganiu zakażeniu osobnika paciorkowcem
|
|
DK1187629T3
(da)
|
1999-04-19 |
2005-01-17 |
Glaxosmithkline Biolog Sa |
Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid
|
|
AU777856B2
(en)
|
1999-06-10 |
2004-11-04 |
Human Genome Sciences, Inc. |
Streptococcus pneumoniae proteins and vaccines
|
|
FR2796291B1
(fr)
|
1999-07-16 |
2001-09-21 |
Cross Site Technologies |
Seringue sans aiguille munie d'un systeme de declenchement piezo-electrique
|
|
FR2796290B1
(fr)
|
1999-07-16 |
2001-09-14 |
Cross Site Technologies |
Seringue sans aiguille fonctionnant avec un generateur d'onde de choc a travers une paroi
|
|
FR2796289B1
(fr)
|
1999-07-16 |
2001-08-10 |
Cross Site Technologies |
Seringue sans aiguille avec injecteur a elements superposes
|
|
US6319224B1
(en)
|
1999-08-20 |
2001-11-20 |
Bioject Medical Technologies Inc. |
Intradermal injection system for injecting DNA-based injectables into humans
|
|
US6494865B1
(en)
|
1999-10-14 |
2002-12-17 |
Becton Dickinson And Company |
Intradermal delivery device including a needle assembly
|
|
FR2800619B1
(fr)
|
1999-11-05 |
2002-02-08 |
Cross Site Technologies |
Seringue sans aiguille avec un moyen de poussee temporairement retenu
|
|
FR2802102B1
(fr)
|
1999-12-08 |
2002-07-12 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille munie d'un tube d'ejection a section constante
|
|
FR2802103B1
(fr)
|
1999-12-08 |
2003-10-03 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille fonctionnant avec entrainement du principe actif par effet tube a choc
|
|
AU1581400A
(en)
|
1999-12-22 |
2001-07-03 |
Om Pharma |
Acyl pseudopeptides bearing a functionalised auxiliary spacer
|
|
FR2802820B1
(fr)
|
1999-12-27 |
2002-10-18 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille fonctionnant par effet tube a choc, avec maintien prealable du principe actif sur le cote
|
|
FR2804329B1
(fr)
|
2000-02-02 |
2002-12-13 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille munie d'un opercule contenant le principe actif
|
|
FR2804869B1
(fr)
|
2000-02-11 |
2002-05-17 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille pour l'injection d'un liquide contenu dans une ampoule pre-remplie
|
|
FR2805749B1
(fr)
|
2000-03-01 |
2002-05-17 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille a deux niveaux de vitesse d'injection
|
|
FR2807946B1
(fr)
|
2000-04-19 |
2002-06-07 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille fonctionnant avec un chargement pyrotechnique bicomposition
|
|
FR2809626B1
(fr)
|
2000-05-30 |
2003-03-07 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille avec membrane d'isolation d'un ejecteur multiconduit
|
|
WO2001098334A2
(en)
|
2000-06-20 |
2001-12-27 |
Shire Biochem Inc. |
Streptococcus antigens
|
|
FR2810554B1
(fr)
|
2000-06-22 |
2003-05-16 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille munie d'un reservoir modulable
|
|
FR2812202B1
(fr)
|
2000-07-28 |
2002-09-13 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille fonctionnant par mise en compression du reservoir contenant le principe actif liquide
|
|
GB0022742D0
(en)
*
|
2000-09-15 |
2000-11-01 |
Smithkline Beecham Biolog |
Vaccine
|
|
FR2815544B1
(fr)
|
2000-10-23 |
2003-02-14 |
Poudres & Explosifs Ste Nale |
Seringue sans aiguille securisee a architecture compacte
|
|
US20030031684A1
(en)
|
2001-03-30 |
2003-02-13 |
Corixa Corporation |
Methods for the production of 3-O-deactivated-4'-monophosphoryl lipid a (3D-MLA)
|
|
CN100443116C
(zh)
|
2002-11-07 |
2008-12-17 |
新纳几美国公司 |
治疗或预防肺炎球菌感染的组合物及其用途
|
|
MXPA05009579A
(es)
|
2003-03-13 |
2005-11-17 |
Glaxosmithkline Biolog Sa |
Proceso de purificacion para citolisina bacteriana.
|
|
WO2005076696A2
(en)
|
2004-02-13 |
2005-08-25 |
Sanofi Pasteur Limited |
Pneumolysin derivatives
|
|
GB0410220D0
(en)
|
2004-05-07 |
2004-06-09 |
Kirkham Lea Ann |
Mutant pneumolysin proteins
|
|
GB0421083D0
(en)
|
2004-09-22 |
2004-10-27 |
Glaxosmithkline Biolog Sa |
Purification process
|
|
GB0525321D0
(en)
*
|
2005-12-13 |
2006-01-18 |
Glaxosmithkline Biolog Sa |
Novel compositions
|
|
TWI457133B
(zh)
*
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
|
JP5792920B2
(ja)
|
2005-12-22 |
2015-10-14 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
ワクチン
|
|
EP2468300B1
(en)
*
|
2006-09-26 |
2017-12-20 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
|
CA2694466A1
(en)
|
2007-07-23 |
2009-01-29 |
Sanofi Pasteur Limited |
Immunogenic polypeptides and monoclonal antibodies
|
|
JP2010534622A
(ja)
|
2007-07-26 |
2010-11-11 |
サノフィ パストゥール リミテッド |
抗原−アジュバント組成物および方法
|
|
GB0724357D0
(en)
|
2007-12-14 |
2008-01-23 |
Glaxosmithkline Biolog Sa |
Method for preparing protein conjugates
|
|
ES2331863B1
(es)
|
2008-07-15 |
2010-10-27 |
Consejo Superior De Investigaciones Cientificas (Csic) |
Bacterias y productos derivados para fortalecer las defensas y reducir el riesgo de enfermedad.
|
|
CN106008679A
(zh)
|
2008-12-24 |
2016-10-12 |
荷兰王国卫生福利和运动部国家公共卫生和环境研究所 |
修饰的肺炎链球菌溶血素(ply)多肽
|
|
WO2010109325A2
(en)
|
2009-03-24 |
2010-09-30 |
Novartis Ag |
Combinations including pneumococcal serotype 14 saccharide
|
|
ES2531115T3
(es)
|
2009-06-01 |
2015-03-10 |
Novartis Ag |
Combinaciones de clados de RrgB neumocócicos
|
|
KR20120107121A
(ko)
|
2009-12-22 |
2012-09-28 |
사노피 파스퇴르 리미티드 |
면역원성 조성물
|